{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:07:18Z","timestamp":1759334838079,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.jaad.2006.04.076","type":"journal-article","created":{"date-parts":[[2008,1,11]],"date-time":"2008-01-11T11:03:15Z","timestamp":1200049395000},"page":"S44-S46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"S1","title":["Chemotherapy-induced toxic erythema under treatment with pegylated liposomal doxorubicin: No\u00a0restriction to palms and soles"],"prefix":"10.1016","volume":"58","author":[{"given":"Mirjana","family":"Ziemer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Goetze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Kaatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Elsner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2006.04.076_bib1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000251603","article-title":"Erythematous eruption of the palms and soles associated with mitotane therapy","volume":"148","author":"Zuehlke","year":"1974","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2006.04.076_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.7326\/0003-4819-101-6-798","article-title":"Chemotherapy-associated palmar-plantar erythrodysesthesia syndrome","volume":"101","author":"Lokich","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2006.04.076_bib3","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1200\/JCO.1995.13.7.1777","article-title":"Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies","volume":"13","author":"Uziely","year":"1995","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2006.04.076_bib4","doi-asserted-by":"crossref","first-page":"6949","DOI":"10.1073\/pnas.85.18.6949","article-title":"Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors","volume":"85","author":"Gabizon","year":"1988","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2006.04.076_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/1097-0142(20000901)89:5<1037::AID-CNCR13>3.0.CO;2-Z","article-title":"Correlation of toxicity with pharmacokinetics of pegylated liposomal doxorubicin (Doxil) in metastatic breast carcinoma","volume":"89","author":"Lyass","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2006.04.076_bib6","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1200\/JCO.1997.15.3.987","article-title":"Phase II study of liposomal doxorubicin in refractory ovarian cancer: antitumor activity and toxicity modification by liposomal encapsulation","volume":"15","author":"Muggia","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jaad.2006.04.076_bib7","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1034\/j.1600-0560.2003.00113.x","article-title":"Intertriginous epidermal dysmaturation from pegylated liposomal doxorubicin","volume":"30","author":"English","year":"2003","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2006.04.076_bib8","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1034\/j.1600-0560.2002.290304.x","article-title":"Host-vs-altered-host eruptions in patients on liposomal doxorubicin","volume":"29","author":"Skelton","year":"2002","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.jaad.2006.04.076_bib9","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00128071-200001040-00004","article-title":"Antineoplastic therapy-induced palmar plantar erythrodysesthesia (\u2018hand-foot\u2019) syndrome: incidence, recognition and management","volume":"1","author":"Nagore","year":"2000","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2006.04.076_bib10","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1002\/1097-0142(19950415)75:8<2169::AID-CNCR2820750822>3.0.CO;2-H","article-title":"Hand-foot syndrome associated with liposome-encapsulated doxorubicin therapy","volume":"75","author":"Gordon","year":"1995","journal-title":"Cancer"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206012849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962206012849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:08:04Z","timestamp":1759270084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962206012849"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0190962206012849"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2006.04.076","relation":{},"ISSN":["0190-9622"],"issn-type":[{"type":"print","value":"0190-9622"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chemotherapy-induced toxic erythema under treatment with pegylated liposomal doxorubicin: No\u00a0restriction to palms and soles","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2006.04.076","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}